Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

FERRING PHARMACEUTICALS INC.

Filed by BROWNSTEIN HYATT FARBER SCHRECK, LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 17, 2025
Income
$50,000.00
Expenses
Not reported
Filing UUID
f99920cb-e832-42d7-b793-c8d991ee7fe4
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA Pharmaceutical tariffs

VET · Veterans

Issues related to veteran's care and veteran's reproductive care

TRD · Trade (domestic/foreign)

Issues related to pharmaceutical tariffs

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.